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Summary
Mycoplasma pneumoniae causes acute and chronic
respiratory infections, including tracheobronchitis
and community acquired pneumonia, and is linked to
asthma and an array of extra-pulmonary disorders.
Recently, we identiﬁed an ADP-ribosylating and vacu-
olating toxin of M. pneumoniae, designated Com-
munity Acquired Respiratory Distress Syndrome
(CARDS) toxin. In this study we analysed CARDS
toxin gene (annotated mpn372) transcription and
identiﬁed its promoter. We also compared CARDS
toxin mRNA and protein proﬁles in M. pneumoniae
during distinct in vitro growth phases. CARDS toxin
mRNA expression was maximal, but at low levels,
during early exponential growth and declined sharply
during mid-to-late log growth phases, which was in
direct contrast to other mycoplasma genes examined.
Between 7% and 10% of CARDS toxin was localized to
the mycoplasma membrane at mid-exponential
growth, which was reinforced by immunogold elec-
tron microscopy. No CARDS toxin was released into
the medium. Upon M. pneumoniae infection of mam-
malian cells, increased expression of CARDS toxin
mRNA was observed when compared with SP-4
broth-grown cultures. Further, confocal immunoﬂuo-
rescence microscopy revealed that M. pneumoniae
readily expressed CARDS toxin during infection of
differentiated normal human bronchial epithelial
cells. Analysis of M. pneumoniae-infected mouse
lung tissue revealed high expression of CARDS toxin
per mycoplasma cell when compared with M. pneu-
moniae cells grown in SP-4 medium alone. Taken
together, these studies indicate that CARDS toxin
expression is carefully controlled by environmental
cues that inﬂuence its transcription and translation.
Further, the acceleration of CARDS toxin synthesis
and accumulation in vivo is consistent with its role as
a bona ﬁde virulence determinant.
Introduction
Mycoplasma pneumoniae is a signiﬁcant bacterial patho-
gen of the airways and accounts for 20–30% of all com-
munity acquired pneumonia. It is also implicated in other
airway diseases including asthma, and in extra-
pulmonary manifestations, including neurological, gas-
trointestinal and dermatological disorders (Baseman and
Tully, 1997; Waites and Talkington, 2004). M. pneumoniae
colonizes the surfaces of epithelial cells and is also
capable of invading host cells and establishing intracellu-
lar residence (Baseman et al., 1995; Dallo and Baseman,
2000). Recently, we identiﬁed a unique virulence factor
designated Community Acquired Respiratory Distress
Syndrome (CARDS) toxin, an ADP-ribosylating and vacu-
olating toxin that binds alveolar surfactant protein A
(Kannan et al., 2005; Kannan and Baseman, 2006), likely
contributing to additional colonization and pathogenic
pathways. CARDS toxin ADP-ribosylates both similar and
distinct human cell proteins when compared with the S1
catalytic subunit of pertussis toxin, leading to a cascade of
events such as tissue disorganization, inﬂammation and
airway dysfunction along with cell vacuolization (Kannan
and Baseman, 2006). Hamster, murine and chimpanzee
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cultures and human cell cultures have provided important
insights in deﬁning M. pneumoniae virulence potential
(Hara et al., 1974; Hu et al., 1975; Barile et al., 1981;
Baseman et al., 1995; Dallo and Baseman, 2000; Hardy
et al., 2002; Kannan and Baseman, 2006). Recently,
normal human bronchial epithelial (NHBE) cells were
used as a model to study M. pneumoniae interactions
(Krunkosky et al., 2007). NHBE cells maintained in the
air–liquid interface culture system exhibit well differenti-
ated heterogenous populations of ciliated and secretory
cells remarkably similar to the lumen of the airway.
Clearly, M. pneumoniae must co-ordinate a wide range
of virulence factors and circumvent host defenses in order
to colonize, propagate, internalize, persist and be
transmitted. Transcriptional and translational regulation in
M. pneumoniae appears to be unique compared with
other procaryotes, as this mycoplasma possesses only
one authentic sigma factor and a limited number of genes
encoding typical transcriptional and translational regula-
tory elements (Himmelreich et al., 1996; Dandekar et al.,
2000), including helix–turn–helix (HTH) motifs (Samuels-
son et al., 1997). Although there is no classical two-
component system in M. pneumoniae (Himmelreich et al.,
1996), there is evidence that M. pneumoniae is able to
differentially regulate gene expression in response to
environmental stimuli. For example, transcriptional regu-
lation of mycoplasma heat shock genes has been
observed in M. pneumoniae and other pathogenic Myco-
plasma species (Weiner et al., 2003; Madsen et al., 2006;
Musatovova et al., 2006; Chang et al., 2008; Kannan
et al., 2008). Differential expression of lipoprotein genes
in M. pneumoniae after acidic and oxidative stresses
(Hallamaa et al., 2008) and regulation of ackA (acetate
kinase) and ldh (lactate dehydrogenase) genes by glyc-
erol (Halbedel et al., 2007) were recently reported. After
contact with human lung epithelial cells, distinct patterns
of M. pneumoniae lipoprotein gene expression were
observed (Hallamaa et al., 2008). While upregulation of
four heat shock genes (dnaJ, dnaK, lon and clpB) can be
attributed to a functioning HrcA-CIRCE regulatory appa-
ratus (Narberhaus, 1999; Weiner et al., 2003), in most
cases the mechanisms of gene expression and regulation
have not been identiﬁed. In addition, little is known regard-
ing post-transcriptional and translational controls in M.
pneumoniae, although evidence from two-dimensional gel
electrophoresis, lipoprotein characterization, cleavage of
signal peptides and phosphorylation analyses suggest
that these processes exist (Razin et al., 1998; Regula
et al., 2000; Ueberle et al., 2002; Jaffe et al., 2004).
Because only a paucity of data is available concerning
regulation of virulence genes in M. pneumoniae,w e
focused on the identiﬁcation of the putative promoter of
the cards gene and monitored cards transcript levels
during M. pneumoniae in vitro growth and after contact
with host cells. We further demonstrated surface localiza-
tion of CARDS toxin on intact mycoplasma cells with no
evidence for release into the environment. Interestingly,
we noted substantial increases in the synthesis of CARDS
toxin protein per mycoplasma cell in infected mice. These
data suggest that understanding how airway-associated
environmental signals regulate CARDS toxin expression
should provide important clues concerning M. pneumo-
niae virulence and associated pathologies.
Results
cards gene organization and promoter mapping
In M. pneumoniae reference strain M129, the cards gene
(mpn372, nucleotides 444341-446116) is ﬂanked by
mpn371 (nucleotides 444187-443552) and mpn373
(nucleotides 446741-446127) genes. Both mpn371 and
mpn373 genes are transcribed from the complementary
strand, in contrast to cards, and encode hypothetical pro-
teins of unknown functions (Fig. 1A). cards is separated
from upstream mpn371 by a 153-nucleotide long inter-
genic region (head-to-head orientation) and from down-
stream mpn373 by a 10-nucleotide short intergenic region
(tail-to-tail orientation). Analysis of all three genes by
reverse transcription PCR (RT-PCR) revealed three tran-
scripts of expected polarity (Fig. 1B). Based on this gene
organization, we predicted cards to have its own
promoter. Primer extension (PE) analysis revealed a
single transcriptional start point (TSP) at 10 nucleotides
upstream of the cards translational start (Fig. 1C). Further
examination of the sequence upstream of the TSP
revealed additional consensus features of M. pneumoniae
promoters, such as the presence of a -10 element
(Pribnow box; TAAAAT; Fig. 1C) four nucleotides
upstream from the identiﬁed TSP. The sequence immedi-
ately 5′ to the -10 element was AT-rich and contained
polythymidine tracts (3 and 5 residues; Fig. 1C). While
there was no strong consensus in the -35 region, the
relatively conserved M. pneumoniae promoter-unique
TTGA (Weiner et al., 2000) was found upstream of the
-10 region. PE analyses did not identify individual tran-
scriptional starts for mpn371 or mpn373. Although tran-
scription of cards was readily conﬁrmed by RT-PCR and
low amounts of transcript were repeatedly demonstrated
by slot blot analysis (Fig. 2A), Northern blot analysis did
not detect cards transcripts (data not shown) possibly
because of low-level expression.
Is expression of cards temporal?
To determine the dynamics of cards transcript expression
during in vitro mycoplasma growth in SP-4 broth, we
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mid-, late-exponential and stationary growth phases of M.
pneumoniae cells. cards mRNA levels were compared
with differential mRNA expression of selected M. pneu-
moniae metabolic genes (tuf, pdhB, pdhA, gap, eno and
nox; Fig. 2A) and adherence- and heat shock-related
genes (Fig. S1). Results indicated that cards expression
occurred at low levels during early stages of growth,
which decreased dramatically as growth progressed
(Fig. 2A). In contrast, other genes exhibited relatively
stable or increased gene transcription throughout growth
(eno, gap, nox, pdhA and pdhB) while tuf exhibited a
similar pattern except at stationary phase where a notice-
able decline in transcription occurred (Fig. 2A).
Adherence- and heat shock-related genes exhibited rela-
tively stable or diminished transcription proﬁles during
mid-to-late log growth phases but, in all cases, increased
transcription was observed during later stages of growth
in direct contrast to cards proﬁles (Fig. S1). To further
conﬁrm the speciﬁcity of cards expression during different
mycoplasma growth intervals, we performed real-time
quantitative reverse transcriptase polymerase chain reac-
tion (qRT-PCR). As indicated in Fig. 2B, the expression of
CARDS toxin transcription decreased dramatically (~130-
fold) between early-log and stationary phases.
Total M. pneumoniae cell protein proﬁles at different
growth stages
In order to compare CARDS toxin protein levels with
other mycoplasma proteins, we harvested mycoplasma
cells during an extended (12–144 h) growth period in
SP-4 broth and analysed protein proﬁles (Fig. 3A). Four
distinct protein patterns were readily observed based
upon SDS-polyacrylamide gel electrophoresis (PAGE)
proﬁles and image analysis. One protein category exhib-
ited increased intensity as mycoplasma growth pro-
ceeded from early to late stages (open arrow). Another
Fig. 1. Chromosomal organization and transcriptional and primer extension analyses of cards (mpn372).
A. Schematic of cards and its surrounding genes. mpn371 and mpn373 encode hypothetical proteins. The orientation of individual genes is
indicated (open arrows), and numbers represent the length of intergenic regions.
B. Transcriptional analysis. RT-PCR was performed on total RNA isolated from M. pneumoniae cells. The thin horizontal arrows represent
regions that were ampliﬁed to conﬁrm transcription of individual genes, and numbers represent sizes of RT-PCR ampliﬁed products.
C. Primer extension (PE) analysis and characterization of cards gene promoter. The PE product was separated by electrophoresis and
analysed alongside DNA sequence (A, T, C and G). The sequence of the intergenic region separating mpn371 and cards is provided. The
translational start sites of mpn371 and cards are indicated (bold letters). A vertical arrow designates the transcriptional start point identiﬁed for
cards. Putative Pribnow box (-10 site), along with M. pneumoniae conserved TTGA sequences, are shaded in gray colour. Poly-T tracts are
underlined.
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appeared during mid-to-late log phase (closed small
arrow). The third category exhibited increased intensity
throughout logarithmic growth, which decreased during
the stationary stage (large closed arrow). The last cat-
egory represented proteins that remained mostly
unchanged (no arrow). We selected speciﬁc proteins
representing adherence- and stress-related functions
(adhesin P1, adhesin P30, PDH-A, PDH-B, EF-Tu and
ClpB) for comparison with CARDS toxin using immuno-
blotting (Fig. 3B). The intensities of immunoreactive
bands demonstrated that CARDS toxin protein levels
peaked between 24 and 48 h and declined to the lowest
levels at 60 h, which continued over the remaining
growth period (60–96 h; Fig. 3B). Other proteins demon-
strated levels of detection consistent with their pattern of
mRNA transcripts (Fig. 2). Growth stage-related dynam-
ics of CARDS toxin mRNA and protein expression are
depicted in Fig. 4 and are compared with the progres-
sion of culture growth (early-log through stationary
phases). These quantitative data clearly reinforce the
selective early synthesis of cards transcripts and
CARDS toxin protein (Fig. 4). Note the relative stability
of CARDS toxin following cards transcriptional decline
(i.e. 60–144 h).
CARDS toxin location in mycoplasma membranes
To assess the location of CARDS toxin in M. pneumoniae
cells, we performed immunoblot analyses on cellular frac-
tions of M. pneumoniae clinical isolate S1. Whole cell
lysates and cytoplasmic, membrane and culture superna-
tant preparations were quantiﬁed for the presence of
CARDS toxin as described in Experimental procedures.I n
parallel, the localization of P1 (major surface-associated
adhesin protein) and EF-G (intracellular cytosolic protein)
was used as control. As shown in Fig. 5A, at 48 h of
mycoplasma growth, CARDS toxin was detected in the
density gradient-puriﬁed membrane fraction, which is free
of intracellular protein contamination (note the absence of
EF-G in lane 2). When compared with total CARDS toxin
concentrations, 7–10% of CARDS toxin was associated
with the mycoplasma membrane fraction. No full-length
CARDS toxin was detected in culture supernatant (data
not shown). Occasionally, we observed two minor CARDS
toxin-related immunoreactive bands of low molecular
weight in the supernatant of 72 and 96 h cultures, which
may represent degraded or processed CARDS toxin
(data not shown). Immunogold labelling and electron
microscopic analysis revealed CARDS toxin distribution
over the entire surface of M. pneumoniae cells, including
Fig. 2. Transcription of cards during in vitro growth of M. pneumoniae in SP-4 broth.
A. Expression of cards along with other genes was analysed by DNA slot blot. M. pneumoniae gene-speciﬁc PCR products (Table S2) were
blotted onto Zeta probe membranes. M. pneumoniae S1 cells were grown and harvested at early-log (24 h), mid-log (48 h), late-log (72 h) and
stationary phases (120 h).
32P-labelled cDNAs generated by reverse transcription of isolated total RNA were used as hybridization probes.
Experiments were repeated three times.
B. Expression of cards by relative real-time quantitative RT-PCR (qRT-PCR). M. pneumoniae S1 cells were grown and RNA isolated at
speciﬁc growth phases. Real-time qRT-PCR was performed using SYBR green chemistry as detailed in Experimental procedures. Experiments
were repeated two times. The average fold differences in expression levels of cards mRNA at various time points (when compared with the
stationary phase) and standard deviations (SD) are presented.
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protein P1 (Fig. 5B).
Expression of CARDS toxin in M. pneumoniae during
co-incubation with HeLa and differentiated NHBE cells
To evaluate the potential role of host cell factors in cards
expression during infection, we incubated HeLa cells
with M. pneumoniae and monitored the expression of
cards after 15, 30 and 60 min. As appears in slot blot
(Fig. 6A), higher expression of cards mRNA was readily
detectable when M. pneumoniae cells were co-incubated
with HeLa cells in contrast to growth in broth culture
alone. Real-time qRT-PCR data revealed that constant
levels of cards transcription were maintained during the
60 min time frame in SP-4 broth whereas a fold increase
in cards transcript levels was detected in M. pneumoniae
cells after 1 h co-incubation with HeLa cells. To further
reinforce the effect of co-incubation on CARDS toxin
expression in M. pneumoniae cells, we used confocal
immunoﬂuorescence microscopy to detect CARDS toxin
synthesis during mycoplasma infection of differentiated
NHBE cells. Mycoplasmas were distributed over NHBE
cell surfaces with concomitant CARDS toxin synthesis.
Z-section analysis of infected NHBE cells revealed
CARDS toxin both outside and inside NHBE cells
(Fig. 7).
Expression of CARDS toxin during infection of mice
In M. pneumoniae-infected pneumonia patients, evidence
for seroconversion against CARDS toxin is striking
(Kannan and Baseman, 2006) indicating that CARDS
toxin is expressed during human infection and is highly
immunogenic. This contrasts with the low transient
expression observed during M. pneumoniae growth in
SP-4 broth (Figs 2 and 3). Since we observed increased
cards transcript levels and readily measurable CARDS
toxin production following co-incubation of mycoplasmas
with host cells (Figs 6 and 7), we analysed the expression
of CARDS toxin during in vivo infection. In intranasally
inoculated mice, M. pneumoniae expressed CARDS toxin
per mycoplasma genome in lung tissues at much higher
levels (~8–40-fold at 24–48 h post infection, respectively)
than during growth in SP-4 broth (Fig. 8).
Discussion
In this report we describe growth-regulated gene expres-
sion in M. pneumoniae, with special interest in the dynam-
Fig. 3. Differential synthesis of M. pneumoniae proteins during in vitro growth. M. pneumoniae S1 cells were grown in SP-4 broth for various
times and samples collected and processed as described in Experimental procedures.
A. Equal amounts of S1 total cell proteins resolved on 4–12% Nu-PAGE gradient gel and stained with Coomassie Blue. Open arrows:
increased protein intensity during early-to-late growth stages. Small closed arrows: decreased protein intensity during mid-to-late growth
stages. Large closed arrows: increased protein intensity during stationary stage.
B. Parallel gel transferred to nitrocellulose membrane for immunoblotting. Membrane strips were cut and treated with respective M.
pneumoniae antibodies. Experiments were repeated two times.
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synthesis in vitro and in vivo. Growth conditions are invari-
ably different in the test tube versus those encountered
during the course of infection. Only recently have tran-
scriptional studies been performed to examine M. pneu-
moniae responses to environmental cues (Weiner et al.,
2003; Halbedel et al., 2004; 2007; Kannan et al., 2008).
None have focused on monitoring bona ﬁde virulence
determinants, like CARDS toxin. Therefore, the informa-
tion provided here represents an essential step in moni-
toring how M. pneumoniae may behave during the
infectious process. With the availability of M.
pneumoniae-puriﬁed recombinant proteins and speciﬁc
antibody reagents, we were able to quantify and correlate
transcriptional analyses with translational responses
between CARDS toxin and a range of M. pneumoniae
proteins.
Using M. pneumoniae clinical strain S1 (Kannan and
Baseman, 2006; Musatovova et al., 2008) we demon-
strated transcription of all three genes (cards and its
adjacent genes: mpn371-mpn373) in their predicted
orientations (Fig. 1). Previously, corresponding gene tran-
scripts were analysed in M. pneumoniae strain M129
before and after temperature shift (Weiner et al., 2003).
We also sequenced the corresponding regions in strain
S1 and found very minimal differences in the sequences
(see Fig. S2). As shown in Fig. 1C, the cards transcript
contains a short 5′-untranslated region (transcription start
point at T-10). Because cards is followed by a gene with
opposite polarity (Fig. 1A), we expected cards to be
~1.8 kb single gene transcript. Recently, such monocis-
tronic messages were shown for M. pneumoniae genes
ldh and ptsH (Halbedel et al., 2004; 2007). However,
repeated Northern blots did not permit visualization of any
clear band for cards. It is possible that the low amount of
transcript we detected (Figs 2 and 4) is further degraded
during isolation. Also possible and contrary to ldh and
ptsH genes, a transcription termination signal is not pre-
dicted for cards (Ermolaeva et al., 2000), and transcripts
of different lengths may be generated.
We investigated CARDS toxin synthesis by measuring
changes in cards transcript levels and comparing these
data with CARDS toxin protein concentrations. This is
important because the relationship between mRNA levels
and rates of protein synthesis can be non-linear
(Vanbogelen et al., 1999). Moreover, protein analysis
makes it possible to study critical post-translational control
mechanisms, such as protein modiﬁcation and stability,
which may contribute greatly to the ultimate properties of a
givenprotein.Althoughweobservedasurprisingdemiseof
Fig. 4. Growth phase-dependent variations in cards mRNA and CARDS toxin protein levels in M. pneumoniae broth cultures. M. pneumoniae
cells were grown at 37°C for 12, 24, 36, 48, 60, 72, 84, 96 and 120 h and harvested at each time interval for analysis. Experiments were
repeated two times. Levels of cards transcript are estimated by DNA slot blot (average value  SD), CARDS toxin protein levels are quantiﬁed
by immunoblot, and mycoplasma growth (total protein) is indicated in grey dotted lines (average value  SD), and expression levels are
presented in arbitrary values.
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in SP-4 medium (Fig. 2B), we still detected CARDS toxin
protein levels late into stationary phase (Figs 3 and 4).The
detection of CARDS toxin many hours after the end of
exponential growth can be explained either by toxin stabil-
ity and/or by its continued low-level synthesis as a result of
residual de novo transcription. In contrast to CARDS toxin,
the toxins of Bortedella pertussis (Rambow-Larsen
and Weiss, 2004) and Staphylococcus aureus (Payne,
2003) are maximally expressed at mid-to-late exponential
growth phases (pertussis toxin) and late- to post-
exponential growth phases (a toxin). Similar high-level
expression of toxins during late-log and stationary phase
growth-related time points was observed in other bacteria
(Thompsonet al.,2003;Wagneret al.,2003;Snyderet al.,
2004). Distinct from cards gene transcription, we observed
high-level expression of adherence- and stress-related
genes during late-log and stationary stage growth of M.
pneumoniae, and similar growth dependent expression
patterns of adherence- and stress-related genes have
been observed in other bacteria (Strohmaier et al., 1995;
Xu and Johnson, 1995; Nicholson et al., 2003; Thompson
et al., 2003).
Earlier, we reported that CARDS toxin was a surface-
associated, trypsin-sensitive surfactant protein A binding
68 kDa protein (Kannan et al., 2005). In the current study,
we further reinforced its cell-associated distribution and
lack of secretion into the medium during mycoplasma
growth in SP-4 broth. Interestingly, only 7–10% of the
toxin appears membrane-bound (Fig. 5A), and immuno-
electron microscopy (Fig. 5B) further conﬁrmed CARDS
toxin surface localization. The majority of toxin is detected
in the cytoplasm, which was conﬁrmed by immunoblot
comparisons between concentrated supernatant (ammo-
nium sulphate precipitated and desalted), total myco-
plasma lysate, membrane fractions and cytoplasmic
fractions (Fig. 5A). Consistent with these results, we could
not identify signal sequence speciﬁc for secreted proteins
in CARDS toxin. Because higher expression of CARDS
toxin is observed when mycoplasmas are co-incubated
with host cells, it is possible that redistribution of toxin
from the mycoplasma cytoplasm to mycoplasma mem-
Fig. 5. Cell fractionation of M. pneumoniae and localization of CARDS toxin.
A. Total lysate, membrane and cytoplasmic fractions of M. pneumoniae cells were isolated as described in Experimental procedures. Equal
amounts of mycoplasma proteins from each fraction were resolved on 4–12% gradient Nu-PAGE gels and transferred to nitrocellulose
membranes. Speciﬁc proteins were identiﬁed by immunoblotting for the presence of CARDS toxin, cytoplasmic EF-G and membrane adhesin
P1. Lane 1. total cell lysate; lane 2. membrane fraction; and lane 3. cytoplasmic fraction.
B. Immunogold electron microscopy detection of CARDS toxin and control proteins P1 and EF-G on intact M. pneumoniae cells. M.
pneumoniae cells were gold particle-labelled with anti-P1, anti-EF-G and anti-CARDS toxin antibodies as described in Experimental
procedures. Mycoplasma cells were visualized with a JEOL 1230 transmission electron microscope. Gold labelling of CARDS toxin revealed
surface membrane distribution throughout the M. pneumoniae membrane and tip organelle (bar = 0.1 mm). Experiments were repeated two
times.
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For example, although most classical bacterial protein
toxins are secreted into the surroundings, some are
displayed on the bacterial surface or released upon
contact with the host. The latter could be a possible sce-
nario for CARDS toxin, as toxin colocalizes with myco-
plasmas during colonization of host cells and can be
detected inside NHBE cells based upon the merging of
DAPI staining with anti-toxin immunostaining (Fig. 7).
Therefore, mycoplasmas and toxin together appear to
follow predictable patterns of other toxin-producing bac-
teria by evading host defenses, adhering to cells and
tissue matrices, spreading within the host, eliciting inﬂam-
matory pathways and degrading host target cells and
tissues for nutritional and survival beneﬁts (Finlay and
Falkow, 1997). Puriﬁed toxins of cholera, tetanus and
diphtheria also serve critical functions in establishing
infection and associated pathologies (Finlay and Falkow,
1997). This is consistent with the characteristic ciliostasis,
cytoplasmic vacuolization, nuclear swelling, and exten-
sive epithelial cell fragmentation and sloughing observed
in hamster tracheal organ cultures infected with M. pneu-
moniae (Hu et al., 1976; Murphy et al., 1980). Importantly,
this pathological pattern parallels observations when
CARDS toxin alone is added to baboon tracheal organ
cultures (Kannan and Baseman, 2006).
As with virulence factors in other pathogens, CARDS
toxin probably relies on other mycoplasma components to
fully potentiate its expression, delivery and impact on the
host. Other possible microbial components include gene
and protein regulatory systems, adherence factors for
colonization and invasion and possible secretion systems
Fig. 6. Differential expression of cards mRNA in M. pneumoniae during co-incubation with HeLa cells.
A. Autoradiographic DNA slot blot analysis for cards and pdhA genes. M. pneumoniae-speciﬁc primers were used to generate
32P-labelled
cDNAs from total RNA isolated from HeLa cells alone, M. pneumoniae cells alone or M. pneumoniae cells co-incubated with HeLa cells for
different time intervals. Experiments were repeated three times.
B. Relative quantiﬁcation of cards mRNA by real-time qRT-PCR. M. pneumoniae S1 cells were co-incubated with HeLa cells for 15, 30 and
60 min as described in Experimental procedures, and RNA was isolated. Real-time qRT-PCR was performed using SYBR green chemistry and
pdhA as a normalizer. Experiments were repeated two times. The average fold differences in expression levels of cards mRNA at various time
points (when compared with the cards mRNA level at time 0) and SD are presented.
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CARDS toxin location is also associated with the tip
organelle in addition to its membrane distribution
(Fig. 5B), a likely scenario is that tip-mediated adherence
brings M. pneumoniae into close contact with host
target cells for delivery of toxin as observed with vibrio
(Srivastava et al., 1980). In addition, CARDS toxin also
can bind to mammalian cell surfaces through SP-A-like
molecules and facilitate colonization, similar to B. pertus-
sis pertussis toxin that appears to assist bacterial adher-
Fig. 7. Localization of CARDS toxin in M. pneumoniae-infected NHBE cells. Fully differentiated NHBE cells grown in air–liquid interface were
infected with M. pneumoniae. Thirty-eight hours post infection, cultures were washed to remove unbound mycoplasmas, submerged in ﬁxative,
processed for laser scanning confocal microscopy and screened using mouse polyclonal anti-CARDS toxin sera. Luminal (A1 and B1) and
cross-sectional (A2 and B2) views of uninfected (A1 and A2) and infected (B1 and B2) NHBE cells are presented. In the latter case, surface
colonization by mycoplasmas and synthesis and distribution of CARDS toxin during infection are readily observed (red). Cross-sectional views
of infected cells reveal intracellular localization of CARDS toxin (arrows). Also, DAPI staining indicates the abundance of surface associated
M. pneumoniae DNA (small blue dots on the respiratory cell surface; B1 and B2). Merged images of the cross-sectional view indicate
colocalization of CARDS toxin with M. pneumoniae at respiratory cell surfaces and also demonstrate that toxin is detectable inside target cells,
possibly free of associated M. pneumoniae. Experiments were repeated three times.
Fig. 8. Differential expression of CARDS
toxin in mice. Mice were infected intranasally
with M. pneumoniae, and lungs were
harvested after 24 and 48 h of infection and
analysed for the presence of CARDS toxin
molecules per M. pneumoniae cell by antigen
capture assay and quantitative real-time PCR
(qPCR). In parallel, M. pneumoniae cells were
grown in SP-4 broth, harvested and analysed
similarly. Numbers of CARDS toxin molecules
per mycoplasma genome in SP-4-grown M.
pneumoniae cells (in vitro) or in lungs of
infected mice (in vivo) are represented by bar
diagrams. Experiments were repeated two
times with three to ﬁve animals of each group
and at each time point.
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1985).
While CARDS toxin expression is transient during M.
pneumoniae growth in SP-4 medium, it was appreciably
increased during contact with human cells (Figs 6 and 7)
suggesting the inﬂuence of host cell factors. This was
further supported by the many-fold increase in CARDS
toxin protein molecules per M. pneumoniae cell ratio in
mice versus broth culture (Fig. 8). The expression of bac-
terial toxins is generally tightly regulated and controlled at
the transcriptional level by virtue of repression and/or
transactivation via speciﬁc regulatory proteins (Gallegos
et al., 1997; Rood, 1998; Hirst, 1999; Payne, 2003; Stibitz,
2003).The transient and decreased expression of CARDS
toxin in M. pneumoniae during in vitro growth, cards tran-
scriptional upregulation during co-incubation with host
cells, detection of CARDS toxin in infected NHBE cells,
CARDS toxin increased synthesis per mycoplasma cell in
mice and the high-titre seroconversion to CARDS toxin in
infected patients (Kannan and Baseman, 2006) suggest
thattheproductionofCARDStoxinisalsocontrolledinvivo
by environmental host signals. Uncovering the physiologi-
cal cues that inﬂuence in vivo mycoplasma growth and
CARDS toxin expression will be critical in clarifying the
pathogen–host interaction and in devising strategies,
including new antimicrobial agents, targeted immuno-
therapies and effective vaccines, to control and prevent M.
pneumoniae-mediated disease progression.
Experimental procedures
Bacterial strains, human tissue cultures, growth
conditions and collection of samples
For growth curve studies, M. pneumoniae S1 cells (Musato-
vova et al., 2008) were grown in 400 ml of SP-4 medium
(4 ¥ 100 ml in 150 cm
2 tissue ﬂasks) and incubated at 37°C
for 72 h. Surface-attached mycoplasmas were harvested,
concentrated, pooled and divided into forty 150 cm
2 tissue
culture ﬂasks, which were incubated at 37°C for 12, 24, 36,
48, 60, 72, 84, 96 and 120 h. Three ﬂasks were collected at
each time interval [one for RNA isolation and two for protein
characterization, colony counts, optical density (OD600) deter-
minations and protein measurements]. For OD600 reading,
cells were washed in phosphate-buffered saline (PBS, pH
7.4) and scraped and passed through syringes with 25-gauge
needles. Additional ﬂasks were used at appropriate time
intervals for membrane isolation and other analyses
described below. Each experiment was repeated at least
three times. All samples were stored at -80°C until use. For
evidence of secreted CARDS toxin during M. pneumoniae
growth in SP-4 broth, culture-grown supernatant samples
were ﬁlter-sterilized using 0.2 mm ﬁlters to remove mycoplas-
mas and then concentrated using ammonium sulphate (30–
80% saturation). Supernatants were dialysed with PBS and
analysed for the presence of CARDS toxin by immunoblot.
Recombinant Escherichia coli cells were grown in Luria–
Bertani (LB) broth or LB agar containing ampicillin
(100 mgm l
-1) at 37°C.
Normal human bronchial epithelial cells were grown in
air–liquid interface as previously described (Krunkosky et al.,
2007). Brieﬂy, NHBE cells (Cambrex, San Diego, CA) were
seeded onto Transwell-clear culture inserts (24.5, 0.45 mm
pore size; Costar, Cambridge, MA) thin-coated with rat tail
collagen type I (Collaborative Res., Bedford, MA). The apical
surfaces of NHBE cells were exposed to a humidiﬁed 95%
air/5% CO2 environment and medium changed daily during
21–28 days of air–liquid culture. To study expression and
localization of CARDS toxin during M. pneumoniae infection
of NHBE cells, stocks of clinical strain S1 were quantiﬁed by
dilution and plating. Prior to infection, M. pneumoniae inocula
were passed 10¥ through 25-gauge needles and added api-
cally to each culture well (50 mycoplasmas: 1 NHBE cell) for
speciﬁc times. Total epithelial cells exposed to apical luminal
surfaces in 1 cm
2 culture inserts were estimated to be
approximately 450 000 by examination of confocal micro-
scopic images from multiple ﬁelds of fully differentiated NHBE
cells. Each experiment was repeated in triplicate.
To further examine experimental conditions that could inﬂu-
ence the degree of expression of cards transcripts in M.
pneumoniae cells, we incubated mycoplasma cell monolay-
ers alone or with HeLa cells (ATCC), the latter had been
resuspended in SP-4 broth supernatant (0.2 mm ﬁltered) from
48 h depleted mycoplasma growth medium in order to elimi-
nate the effect of fresh SP-4 components on cards
expression. Ten millilitres of depleted mycoplasma growth
medium suspended HeLa cells was overlaid on mycoplasma
monolayers for 15, 30 and 60 min. Test samples were col-
lected at speciﬁc intervals, RNA isolated each time and DNA
blot slot blots and real-time qRT-PCR performed. Experi-
ments were repeated at least two times for each experiment.
DNA manipulations, primer design and DNA slot
blot construction
Mycoplasma pneumoniae chromosomal DNA was isolated
using Easy-DNA kit (Invitrogen, Carlsbad, CA), quantiﬁed by
OD260, and 100 ng were used in ampliﬁcation reactions.
Sequences of selected genes were obtained from NCBI data-
bases, and primers for PE analysis, RT-PCR and ampliﬁca-
tion of genomic regions of selected genes were designed
(Table S1).
To obtain sequencing templates in PE analysis, corre-
sponding regions of the M. pneumoniae chromosome were
ampliﬁed using speciﬁc primers and high-ﬁdelity AccuTaq LA
DNA polymerase (Sigma-Aldrich, St. Louis, MO). Generated
amplicons were TA-cloned into pCR2.1 and transformed into
TOP10 cells following manufacturer’s instruction (Invitrogen).
Recombinant plasmids were puriﬁed from E. coli cultures
using the QIAprep spin kit (Qiagen, Valencia, CA).
For DNA slot blot construction, speciﬁc regions of selected
M. pneumoniae genes were ampliﬁed using corresponding
primers (Table S2) and high-ﬁdelity AccuTaq LA DNA poly-
merase (Sigma-Aldrich). All generated amplicons were puri-
ﬁed by gel extraction, and 200 ng of each speciﬁc PCR
product was blotted in triplicate on Zeta probe membranes by
using Bio-Dot SF microﬁltration apparatus as suggested by
the manufacturer (Bio-Rad Laboratories, Hercules, CA).
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Total RNAfrom M. pneumoniae was isolated with RNase-free
reagents and plastic ware. Surface-adherent mycoplasmas
alone and M. pneumoniae cells co-incubated with HeLa cells
were washed twice with 25 ml of ice-cold PBS. Sixteen mil-
lilitres of TriReagent (Sigma-Aldrich) was added to each T150
ﬂask, and RNA was extracted as suggested by the
manufacturer. Pellets were dissolved in RNase-free water
and quantiﬁed at 260 nm. RNA was subjected to DNase I
treatment (Gibco-BRL) prior to further use.
To determine TSP we performed PE with primers that were
end-labelled with [g-
32P]-ATP using polynucleotide kinase
(United States Biochemical, Cleveland, OH). Twenty-ﬁve
micrograms of total mycoplasma RNAand 15–20 ng of radio-
labelled primer were heated to 70°C for 10 min and cooled
slowly. After annealing, 5 mlo f1 0 ¥ reverse transcription
buffer (200 mM Tris-HCl, pH 8.4, 500 mM KCl), 5 mlo f2 5m M
MgCl2,5ml of 100 mM dithiothreitol, 2.5 ml of 5 mM dNTPs
and 1 ml of Superscript II RT (Gibco-BRL) were added, and
PE was performed at 42°C. PE reactions were terminated by
incubation at 70°C for 15 min, E. coli RNase H (2 units per
sample) added, and incubation continued at 37°C for 20 min.
Individual PE products were phenol–chloroform extracted,
precipitated with ethanol and dissolved in 6 mlo fH 2O and 3 ml
of loading buffer. Five microlitres of each sample was analy-
sed in 6% sequencing gels alongside sequencing reactions
(dsDNA Cycle Sequencing System, Gibco-BRL) generated
with the same end-labelled oligonucleotide and recombinant
plasmid containing corresponding sequence.
Transcription of mpn371, cards and mpn373 genes was
demonstrated by RT-PCR using isolated RNA. Five micro-
grams of total RNA was subjected to DNase I treatment
(Gibco-BRL), and individual reactions were performed with
corresponding antisense primers (Table S1) and SuperScript
ﬁrst-strand synthesis system as suggested by the manufac-
turer (Gibco-BRL). Generated complementary DNAs were
used in PCR with appropriate primers (Table S1) by standard
procedures. PCR products were analysed in 1% agarose.
Chromosomal DNA was used with each set of primers to
demonstrate ampliﬁcation of a single speciﬁc region in each
reaction.
Relative quantiﬁcation of cards transcription was done by
the comparative CT (DDCT) method in two-step real-time qRT-
PCR using SYBR Green chemistry. Prior to RNA analysis,
cards- and pdhA-speciﬁc primers (Table S1, MPN372P/M
and MPN393P/M, respectively; the later served as a normal-
izer) were examined for speciﬁcity. Melting curves of ampli-
cons conﬁrmed generation of a single speciﬁc product in
each reaction. Using primers with HeLa chromosomal DNA
yielded no product. Validation of the assay was done using
primer sets with serial dilutions of S1 chromosomal DNA. For
analysis, 2 mg of total RNA was treated with DNase I (Invit-
rogen) and ﬁrst-strand cDNA was synthesized using reverse
cards- and pdhA-speciﬁc primers and SuperScript reverse
transcriptase as suggested by manufacturer (Invitrogen).
PCR reactions (50 ml) contained 25 ml of SYBR Green PCR
Master Mix (Applied Biosystems), 2.0 ml of generated cDNAs
(diluted 1:10) and corresponding primer set (1 mM each) and
ampliﬁcation was performed under default conditions using
ABI PRISM 7900HT SDS (Applied Biosystems). All reactions
were run in triplicate and plates included cDNA synthesis
reactions without added reverse transcriptase (controls for
DNA contamination). When analysing the mycoplasma
response to co-incubation with HeLa cells, cDNA synthesis
reactions performed on RNA isolated from uninfected HeLa
cells were also included. Analysis was done using RQ
Manager 1.2 (Applied Biosystems). cards transcript amounts
are represented as a fold change with corresponding stan-
dard deviation.
Hybridization probes for slot blot analysis were also gen-
erated using the SuperScript ﬁrst-strand synthesis system
(Gibco-BRL). Twenty-ﬁve micrograms of RNA plus a mixture
containing 0.2 mM of each gene-speciﬁc antisense oligo-
nucleotide (Table S2) were heated to 70°C for 10 min and
cooled to room temperature. Reverse transcription was per-
formed with both [a-
32P]dCTP and [a-
32P]-TTP (NEN) replac-
ing corresponding nucleotides in the reaction buffer.
Reactions were heat inactivated at 70°C for 15 min, and E.
coli RNase H (2 units per sample) was added prior to a
20 min incubation at 37°C. After unincorporated nucleotides
were removed by gel ﬁltration using G-25 Sephadex column
chromatography (Roche), an equal volume of formamide was
added. Denatured (boiling for 5 min) probes were added to
hybridization buffer.
Hybridization and data analysis
Blots were prehybridized for 4 h at 42°C in prehybridization
solution [50% formamide, 120 mM Na2HPO4, 250 mM NaCl,
7% sodium dodecyl sulphate (SDS), 1 mM EDTA] and hybrid-
ized (prehybridization solution containing appropriate probes)
at 42°C for 18 h. Membranes were washed at room tempera-
ture for 15 min in 2¥ SSC (1¥ SSC is 0.15 M NaCl plus
0.015 M sodium citrate)/0.1% SDS, 30 min in 0.5¥ SSC/0.1%
SDS and 30 min in 0.1¥ SSC/0.1% SDS. After posthybridiza-
tion washes, all membranes were sealed in plastic bags and
placed in a PhosphorImager cassette.
Individual PhosphorImager screens were analysed using
PhosphorImager 400E (Molecular Dynamics) with a pixel
size of 176 mm, and resulting image ﬁles were assessed by
determining pixel density for each band using ImageQuant
(version 5.0) (Molecular Dynamics). Numeric ﬁles were
exported into a Microsoft Excel spreadsheet for analysis. To
analyse transcript amounts for different experimental condi-
tions, we expressed values as percentage of pdhA transcript
amount after background subtraction.
Expression and puriﬁcation of recombinant
M. pneumoniae proteins and immunoblot analysis
Recombinant N-terminal His-tagged M. pneumoniae CARDS
toxin, ClpB (Kannan et al., 2008), DnaK, PDH-A, PDH-B,
EF-Tu and carboxyl P1 truncation (unpublished data) were
overexpressed in E. coli BL21(DE3) cells and puriﬁed using
Ni-NTA (nickel-nitrilotriacetic acid) column chromatography
(Kannan and Baseman, 2006). Veriﬁcation of fusion proteins
was performed by SDS-PAGE, Coomassie blue staining and
immunoblotting with rabbit- or mouse-speciﬁc antisera. Con-
centrations of all proteins were determined by BCA protein
assay (Pierce, Rockford, IL). For measurement of each M.
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using polyclonal rabbit or mouse antisera generated against
M. pneumoniae CARDS toxin, ClpB, P1, P30, EF-Tu, PDH-B
and Mycoplasma genitalium PDH-A and DnaK. To quantify
protein expression by immunoblotting, a dilution series of
each puriﬁed recombinant protein was loaded onto individual
gels, probed with corresponding antibodies and signal
strengths determined by densitometry. Quantiﬁcation of band
intensities was performed by scanning immunostained bands
and analysing images with KODAK Image software. Using
Microsoft Excel linear regression, we estimated protein con-
centrations in test samples, which were compared with stan-
dard curves. As necessary, samples were diluted so that the
amount of loaded protein fell within the linear range of
standards. Relative levels of protein expression were
determined by comparing test unknowns to the 24 h sample
as an internal standard. Transcript or protein amounts
are represented in means with corresponding standard
deviation.
Separation of mycoplasma membrane, cytoplasmic
and secreted proteins
In order to localize CARDS toxin in speciﬁc mycoplasma cell
fractions, M. pneumoniae S1 cells were grown in SP-4 broth
as described above. Cell cultures were harvested at 24, 48,
72 and 96 h by scraping and centrifugation, washed two
times in 10 ml of 4°C Tris-NaCl [20 mM Tris-HCl (pH 7.4),
200 mM NaCl, 1 mM EDTA] and suspended in 1 ml of Tris-
NaCl containing 20 ml of protease inhibitor cocktail (Sigma-
Aldrich). Mycoplasma cells were disrupted by osmotic shock
and sonication as detailed by us earlier (Dallo et al., 2002).
Then, samples were centrifuged at 100 000 g for 1 h to sepa-
rate membrane and cytosolic cell fractions. Cytosolic frac-
tions were precipitated with trichloroacetic acid at 20%
saturation for 30 min on ice, suspended in 1 ml of Tris-NaCl
and divided into 100 ml of aliquots or concentrated using
Amicon centrifugal ﬁlter (Millipore; 3 kDa cutoff). Membrane
fractions were further puriﬁed by sucrose gradient centrifuga-
tion to separate from unbroken cells. Then, enriched mem-
brane fractions were suspended in 1 ml of Tris-NaCl,
sonicated for 1 min, divided into 100 ml of aliquots, and mem-
brane yield calculated relative to total cell lysate (Razin,
1983). To analyse secreted proteins, broth supernatants
(500 ml) from mycoplasma cultures at each time point (24,
48, 72 and 96 h) were precipitated by ammonium sulphate in
a three stepwise concentration (30%, 50% and 85%)
(Englard and Seifter, 1990). Pellets from each ammonium
sulphate fraction were resuspended in PBS containing pro-
tease inhibitors, dialysed against the same buffer, concen-
trated by Amicon centrifugal ﬁlter (Millipore; 3 kDa cutoff) and
divided into 100 ml of aliquots. Membrane and supernatant
fractions were stored at -80°C, and equal amounts of pro-
teins were examined by immunoblotting for the presence of
CARDS toxin (anti-rabbit antisera 1:2000), cytoplasmic EF-G
(anti-rabbit sera 1:1000, gift from Dr Richard Herrmann) and
membrane adhesin P1 (anti-mouse monoclonal antibody
1:2000). Based on immunoblot band intensities in each frac-
tion and by membrane yield (constitutes ~9–10% of the total
protein), the percentage of membrane-associated CARDS
toxin was determined.
Immunogold electron microscopy of CARDS toxin
location in M. pneumoniae
Immunogold labelling of M. pneumoniae cells was performed
as reported previously (Dallo et al., 2002; Balasubramanian
et al., 2008). Forty-eight hour cultures of SP-4-grown M.
pneumoniae cells were washed with 100 mM Tris-HCl buffer
(pH 7.5) containing 1% BSA and 1% heat-inactivated goat
serum and incubated individually with anti-CARDS toxin,
anti-P1 or anti-EF-G rabbit antisera at 1:100 dilution for
120 min at room temperature. After incubation for 60 min at
room temperature with goat anti-rabbit IgG-gold (20 nm par-
ticles) complex diluted 1:40 in PBS, pH 7.4, with 1% BSA, M.
pneumoniae cells were mounted on Formvar-coated nickel
grids and ﬁxed with 1% glutaraldehyde/4% formaldehyde for
20 min at room temperature. Individual grids were examined
with a JEOL 1230 transmission electron microscope at 80 kV
accelerating voltage after staining with 7% uranyl acetate
followed by Reynolds lead citrate.
Immunostaining and confocal microscopy to detect
CARDS toxin in NHBE cells
For immunostaining of infected and control differentiated
NHBE cells, airway cultures were gently washed with PBS
and ﬁxed with 4% paraformaldehyde (v/v) diluted in PBS
containing 0.05% Tween (PBST). Fixed cells were perme-
abilized for 15 min with PBST containing 0.1% Triton X-100
(v/v), washed in PBST and incubated for 1 h at room tem-
perature in blocking solution consisting of 10% normal goat
serum diluted in PBST (v/v). Cells were then probed over-
night at 4°C with mouse anti-CARDS toxin serum diluted
1:400 in blocking solution. The following day cells were
washed with PBST and incubated for 1.5 h with Cy-5-
conjugated anti-mouse IgG (Jackson ImmunoResearch
Laboratories, West Grove, PA) diluted 1:75 in blocking solu-
tion. Cells were next washed with PBST followed by nuclei
and actin counterstaining for 20 min using 1 mg ml
-1 DAPI
and 2 U ml
-1 of Alexa Fluor 488-labelled phalloidin (Molecu-
lar Probes, Eugene, OR) respectively. After washing cells
with PBST, membranes were excised from Transwell sup-
ports and mounted on slides containing Citiﬂuor antifade
(Ted Pella, Redding, CA). Optical sections of DAPI, Alexa
Fluor 488 and Cy-5 ﬂuorescence were imaged and recon-
structed using a Leica TCS SP2 spectral confocal micro-
scope (Leica Microsystems, Exton, PA).
Animals and inoculation
Two-month-old mycoplasma- and murine virus-free female
BALB/c mice (Charles River and Harlan) were housed in
ﬁlter-top cages and allowed to acclimate to their new envi-
ronment for 1 week. As detailed earlier (Hardy et al., 2001),
mice were intranasally inoculated once (day 0) with
2.5–7 ¥ 10
7 genomes of M. pneumoniae in 50 ml of SP-4
broth. Control mice were inoculated with sterile SP-4 broth.
Animal guidelines were followed in accordance with the Insti-
tutional Animal Care and Research Advisory Committee at
The University of Texas Southwestern Medical Center at
Dallas.
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Lung samples were obtained at 1 and 2 days post infection.
At each time point, infected mice and SP-4-inoculated control
mice (ﬁve each) were utilized as the source of specimens.
Frozen lungs were placed in PBS containing protease inhibi-
tors (Roche), precooled to 4°C and disrupted for 3 ¥ 90 s at
20 Hz in the presence of 5 mm stainless steel beads using
TissueLyserII (Qiagen). Resultant lysates (50–100 mg) were
used to evaluate the number of M. pneumoniae genomes and
CARDS toxin protein levels. Lung samples from both control
and infected mice at different time intervals were subjected to
DNA isolation, and mycoplasma genomes were determined
by qPCR using P1 adhesin (MPN141) sequences as
described previously (Ursi et al., 2003). Standard curves
were established using M. pneumoniae S1 chromosomal
DNA serially diluted from 10
7 to 1 copy per reaction. To
conﬁrm the absence of interference and cross-binding, stan-
dard curves were evaluated with DNAisolated from tissues of
non-infected mice. All reactions were performed in triplicate
using TaqMan Universal PCR Master Mix, 0.5 mM concentra-
tion of M. pneumoniae-speciﬁc primers and 0.2 mM concen-
tration of appropriate probe. Ampliﬁcation conditions
consisted of 50°C for 2 min, 95°C for 10 min and 40 cycles of
95°C for 15 s and 60°C for 1 min. Real-time PCR was done
using ABI PRISM HP7900 SDS (Applied Biosystems).
To quantify the amount of CARDS toxin in individual
samples, toxin ‘antigen capture’assays were performed. Flat-
bottom, 96-well microtitre enzyme-linked immunosorbent
assay (ELISA) plates (HBX 4, Dynatech, Alexandria, VA)
were coated with 50 ml of rabbit anti-CARDS toxin IgG
(10 mgm l
-1). Plates were blocked with 3% BSA for 2 h at
room temperature and washed with PBS containing 0.05%
v/v polyoxyethylene sorbitan monolaurate (Tween-20,
Sigma-Aldrich) (PBST). Ten microlitres of extracted lung
sample or SP-4-grown M. pneumoniae cells was mixed with
1% BSA/PBST to a ﬁnal volume of 50 ml and added to indi-
vidual wells in triplicate. In order to quantify the amount of
CARDS toxin in a given sample, known amounts of highly
puriﬁed CARDS toxin (ranging from 10 pg to 10 ng well
-1)
were added to separate anti-CARDS toxin-coated wells and
run in parallel in each ELISA plate. After 2 h incubation at
room temperature, wells were washed with PBST, 50 mlo f
1/2000 diluted affinity-puriﬁed HRP-conjugated anti-CARDS
toxin IgG (0.5 mgm l
-1) in 1% BSA/PBST was added, and
plates were incubated at room temperature for 2 h. Plates
were washed as before, and 50 ml of enhanced K-blue TMB
substrate solution (Neogen, Lexington, KY) was added to
wells. Incubation was continued for 10 min at room tempera-
ture until reactions developed colour.Assays were terminated
by adding 0.05 ml of 1N HCl. Optical densities (OD) at
450 nm were determined in an automatic ELISA plate reader
(Dynatech, Alexandria, VA) and buffer without test material
served as background OD450 = 0. Data are expressed as
mean  SD from at least three to ﬁve animals from each time
point of two experiments except where otherwise indicated.
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